Lifestyle

LifestyleDecember 1, 2022

Cannabis and Psychedelics Join Forces at the Arcview Access & Cannabis Investment Summit

LifestyleDecember 1, 2022

What is Nucleus?: A Webinar w/ CEO, Logan Lenz

LifestyleSeptember 27, 2022

Genetics and Psychedelics: Do You Inherit Your Trip?

LifestyleSeptember 22, 2022

Colorado Votes For Psilocybin Access

LifestyleSeptember 20, 2022

San Francisco’s Decriminalization: What Does It Mean?

LifestyleSeptember 15, 2022

Psychedelic Analogues Solve The Problems Of Limiting Psychedelic Treatment Model

LifestyleSeptember 13, 2022

Dreams, Psychedelics, and Their Linked Hallucinations

InterviewsSeptember 9, 2022

VIDEO: Interview with Josh Bartch, CEO of Mydecine Innovations Group

LifestyleSeptember 6, 2022

Mydecine Repositions For A Successful Future

LifestyleAugust 31, 2022

The 1960s vs. Today: Psychedelic Use and Common Trends

LifestyleAugust 30, 2022

Thailand is Reconsidering Magic Mushroom Laws

LifestyleAugust 23, 2022

The Shifting Landscape of Psychedelic Biotechnology Investments

LifestyleAugust 17, 2022

Psychedelics As A Non-Habit Forming Anxiety Treatment

LifestyleAugust 11, 2022

New Study Could Lead To Paradigm Shift In The Treatment of Depression

LifestyleAugust 8, 2022

Treating Opioid Addiction with Ibogaine – Could This Be the Future?

LifestyleAugust 4, 2022

Psychedelics Could Disrupt the $42 Billion a Year Rehab Industry

LifestyleAugust 2, 2022

Many Counties Are Voting To Opt Out – But That Doesn’t Mean The End Of Measure 109

LifestyleAugust 1, 2022

Investment Opportunities in Measure 109

LifestyleJuly 28, 2022

Is This the End Of the Psychedelic PR Crisis?

LifestyleJune 17, 2022

Photos from Our Investor Event in San Francisco

LifestyleApril 17, 2020

The Future of Treating Mental Health with Psychedelics

LifestyleApril 13, 2020

Origins of the 1960’s “Psychedelic” Designs

LifestyleMarch 31, 2020

Can Psychedelics Make you a Better Parent?

LifestyleMarch 30, 2020

Street Names Hurt Credibility of Psychedelic Therapy